Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

204.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 58,011
  • Market Cap: £204.50m
  • RiskGrade: 125
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 91.02 (89.52) (90.32)p n/a n/a n/a n/a 0.0%
31-Dec-24 125.10 (41.42) (42.40)p n/a n/a n/a n/a 0.0%
31-Dec-25 157.59 (23.32) (27.70)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
31-Dec-2024 125 125 125 119 136 158
31-Dec-2025 158 158 157 151 170 n/a
 
Earnings
31-Dec-2024 n/a n/a n/a n/a n/a n/a
31-Dec-2025 n/a n/a n/a n/a n/a n/a
 
Dividend
31-Dec-2024 n/a n/a n/a n/a n/a 0.25p
31-Dec-2025 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 1 1 1 1 0 3
Buy 2 2 2 2 3 3
Neutral 7 7 7 7 7 3
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 10 10 10 10 10 9
 
Average Rec 6.00 6.00 6.00 6.00 5.75 7.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

OXB Market Data

Currency UK Pounds
Share Price 204.50p
Change Today -0.50p
% Change -0.24 %
52 Week High 470.00
52 Week Low 166.80
Volume 58,011
Shares Issued 100.00m
Market Cap £204.50m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.39% above the market average41.39% above the market average41.39% above the market average41.39% above the market average41.39% above the market average
81.13% above the sector average81.13% above the sector average81.13% above the sector average81.13% above the sector average81.13% above the sector average
Price Trend
76.39% below the market average76.39% below the market average76.39% below the market average76.39% below the market average76.39% below the market average
12.28% below the sector average12.28% below the sector average12.28% below the sector average12.28% below the sector average12.28% below the sector average
Income Not Available
Growth
5.53% above the market average5.53% above the market average5.53% above the market average5.53% above the market average5.53% above the market average
51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 7
Sell 0
Strong Sell 0
Total 10
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
09:13 1,000 @ 205.00p
09:04 185 @ 204.50p
09:04 70 @ 204.00p
09:04 52 @ 204.00p
09:04 72 @ 204.00p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page